Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   168,823    

Indirect Shares

  417,826      
Direct Value   $4,894,341    

Indirect Value

  $13,407,961      
Total Shares   586,649      
Total Value   $18,302,302      


Agios Pharmaceuticals Inc
 $4,299,890 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $7,174 Denali Therapeutics Inc.
 $314,307 Regeneron Pharmaceuticals Inc
 $272,970 Agios Pharmaceuticals Inc
 $4,299,890 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $7,174 Denali Therapeutics Inc.
 $314,307 Regeneron Pharmaceuticals Inc
 $272,970
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 13.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2023-06-01 15,529 2023-06-01 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    153         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive OfficerOfficer   •       •       •   2013-07-23 3 IO $0.00 $0 I/I 0 374,544 -
FMI Foundation Medicine, Inc. Director   –       •      –    2013-09-24 3 IO $0.00 $0 D/D 0 31,250 -
FMI Foundation Medicine, Inc. Director   –       •      –    2013-09-30 4 A $0.00 $0 I/I 62,500 31,250 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-03-10 4 OE $0.30 $16,335 I/I 54,000 241,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-03-25 4 OE $0.30 $7,563 I/I 25,000 266,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-07-01 4 AS $46.52 $604,760 I/I (13,000) 180,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-08-01 4 AS $39.17 $331,770 I/I (8,470) 176,537 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-08-11 4 AS $40.17 $181,970 I/I (4,530) 174,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-02 4 AS $46.30 $601,900 I/I (13,000) 167,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-02 4 OE $0.30 $1,966 I/I 6,500 259,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-26 4 OE $0.30 $9,075 I/I 30,000 283,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-26 4 AS $62.68 $3,760,800 I/I (60,000) 137,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-10-01 4 OE $0.30 $756 I/I 2,500 255,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-10-01 4 AS $60.07 $780,910 I/I (13,000) 131,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-11-03 4 AS $81.71 $1,062,230 I/I (13,000) 124,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-12-01 4 AS $97.03 $1,261,390 I/I (13,000) 118,272 0 -
BLUE Bluebird Bio, Inc. Director   –       •      –    2014-12-19 4 B $85.00 $99,960 D/D 1,176 1,176 2.39 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-01-02 4 AS $110.08 $1,431,040 I/I (13,000) 111,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-02 4 AS $114.31 $1,188,824 I/I (10,400) 107,872 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-11 4 AS $120.14 $94,550 I/I (787) 107,085 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-13 4 AS $120.31 $82,292 I/I (684) 106,401 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-27 4 OE $0.30 $7,563 I/I 25,000 248,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-03-02 4 AS $107.05 $834,990 I/I (7,800) 105,101 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-03-05 4 AS $110.16 $286,416 I/I (2,600) 102,501 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-03-12 4 GD $0.00 $0 I/I 190 94,511 0 -

  153  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed